Cargando…

Cardiogenic Differentiation of Murine Bone Marrow-Derived Mesenchymal Stem Cells by 5-Azacytidine: A Follow-up In vitro Study

BACKGROUND: Cell-based therapy is a promising tool in the management of myocardial infarction. AIM OF THE WORK: The aim of this study is to examine the in vitro potential differentiation of murine bone marrow (BM)-derived stem cells into cardiomyocytes using 5-azacytidine after 1, 3, and 5 weeks and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharaf Eldin, Heba E. M., Ibrahim, Marwa A. A., Mousa, Amany M. I., Metwaly, Hala G., Abo-Hassan, Nadia F. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880314/ https://www.ncbi.nlm.nih.gov/pubmed/31803573 http://dx.doi.org/10.4103/JMAU.JMAU_17_19

Ejemplares similares

Cardiogenic and Myogenic Gene Expression in Mesenchymal Stem Cells After 5-Azacytidine Treatment
por: Supokawej, Aungkura, et al.
Publicado: (2013)

Effect of 5-azacytidine on the Protein Expression of Porcine Bone Marrow Mesenchymal Stem Cells in vitro
por: Ye, Neng-Sheng, et al.
Publicado: (2006)

Up‐regulation of SPINT2/HAI‐2 by Azacytidine in bone marrow mesenchymal stromal cells affects leukemic stem cell survival and adhesion
por: Roversi, Fernanda Marconi, et al.
Publicado: (2018)

The Modulatory Effects of Mesenchymal Stem Cells on Osteoclastogenesis
por: Sharaf-Eldin, Wessam E., et al.
Publicado: (2016)

5-Azacytidine-Mediated Modulation of the Immune Microenvironment in Murine Acute Myeloid Leukemia
por: Ebelt, Nancy D., et al.
Publicado: (2022)

Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?
por: Yang, Sirui, et al.
Publicado: (2013)

Development of an Oral Form of Azacytidine: 2′3′5′Triacetyl-5-Azacytidine
por: Ziemba, Amy, et al.
Publicado: (2011)

Azacytidine Treatment for VEXAS Syndrome
por: Raaijmakers, Marc H. G. P., et al.
Publicado: (2021)

Modulation of Cell Cycle Progression by 5-Azacytidine Is Associated with Early Myogenesis Induction in Murine Myoblasts
por: Montesano, Anna, et al.
Publicado: (2013)

Osteogenic Differentiation Potential of Human Bone Marrow and Amniotic Fluid-Derived Mesenchymal Stem Cells in Vitro & in Vivo
por: Mohammed, Eman E. A., et al.
Publicado: (2019)

Azacytidine (Vidaza®) in the treatment of myelodysplastic syndromes
por: Raj, Kavita, et al.
Publicado: (2006)

Teriflunomide restores 5-azacytidine sensitivity via activation of pyrimidine salvage in 5-azacytidine-resistant leukemia cells
por: Imanishi, Satoshi, et al.
Publicado: (2017)

Differentiation of Bone Marrow Mesenchymal Stem Cells to Cardiomyocyte-Like Cells Is Regulated by the Combined Low Dose Treatment of Transforming Growth Factor-β1 and 5-Azacytidine
por: Shi, Shutian, et al.
Publicado: (2016)

5-Azacytidine restores interleukin 6-increased production in mesenchymal stromal cells from myelodysplastic patients
por: Boada, Matilde, et al.
Publicado: (2021)

The prognostic value of p53 mutation in pediatric marrow hypoplasia
por: Abo-Elwafa, Hasnaa A, et al.
Publicado: (2011)

The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry
por: Diamantopoulos, Panagiotis, et al.
Publicado: (2019)

5-Azacytidine and Resveratrol Enhance Chondrogenic Differentiation of Metabolic Syndrome-Derived Mesenchymal Stem Cells by Modulating Autophagy
por: Marycz, K., et al.
Publicado: (2019)

Direct-Acting Antiviral Drugs and Occurrence of Hepatocellular Carcinoma: Unjust or Oppressed
por: Hassany, Sahar M, et al.
Publicado: (2020)

A Comparative Analysis of 5-Azacytidine- and Zebularine-Induced DNA Demethylation
por: Griffin, Patrick T., et al.
Publicado: (2016)

Cytogenetic effect of 5-azacytidine in patients with hematological malignancies
por: Tsuda, Jessica Romy, et al.
Publicado: (2011)

CNS Involvement in AML Patient Treated with 5-Azacytidine
por: Vasilatou, Diamantina, et al.
Publicado: (2014)

Suppressing nonsense—a surprising function for 5-azacytidine
por: Shao, Ada, et al.
Publicado: (2014)

5-Azacytidine in Chronic Myelomonocytic Leukemia: Case Report and Review of Literature.
por: Greco, M., et al.
Publicado: (2011)

Retraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML
por: Dubois, Alix, et al.
Publicado: (2020)

5-Azacytidine Improves the Osteogenic Differentiation Potential of Aged Human Adipose-Derived Mesenchymal Stem Cells by DNA Demethylation
por: Yan, Xueying, et al.
Publicado: (2014)

Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
por: Chau, David, et al.
Publicado: (2015)

Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports
por: Rohon, Peter, et al.
Publicado: (2012)

Effects of 5-Azacytidine on Growth and Hypocrellin Production of Shiraia bambusicola
por: Ma, Yan Jun, et al.
Publicado: (2018)

A cat with myelodysplastic syndrome by administration of the methylation inhibitor Azacytidine
por: HISASUE, Masaharu, et al.
Publicado: (2021)

Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma
por: Laribi, Kamel, et al.
Publicado: (2022)

Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy
por: Xu, Ning, et al.
Publicado: (2021)

Re-Expression of Bone Marrow Proteoglycan-2 by 5-Azacytidine is associated with STAT3 Inactivation and Sensitivity Response to Imatinib in Resistant CML Cells
por: Al-Jamal, Hamid Ali Nagi, et al.
Publicado: (2018)

Immune responses to azacytidine in animal models of inflammatory disorders: a systematic review
por: Landman, Sija, et al.
Publicado: (2021)

The Impact of Confluence on Bone Marrow Mesenchymal Stem (BMMSC) Proliferation and Osteogenic Differentiation
por: Abo-Aziza, Faten A.M., et al.
Publicado: (2017)

5-azacytidine inhibits nonsense-mediated decay in a MYC-dependent fashion
por: Bhuvanagiri, Madhuri, et al.
Publicado: (2014)

Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells
por: Wilson, Amber, et al.
Publicado: (2010)

NMD inhibition by 5-azacytidine augments presentation of immunogenic frameshift-derived neoepitopes
por: Becker, Jonas P., et al.
Publicado: (2021)

5-Azacytidine Is Insufficient For Cardiogenesis In Human Adipose-Derived Stem Cells
por: Wan Safwani, Wan Kamarul Zaman, et al.
Publicado: (2012)

Azacytidine induces necrosis of multiple myeloma cells through oxidative stress
por: Tian, Enbing, et al.
Publicado: (2013)

Alterations of immune response of non-small cell lung cancer with Azacytidine
por: Wrangle, John, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rvuv0odrn9j4ha8v7c7lmk0ujd